Skip to content

The effect of low-dose radiotherapy on pain in mild osteoarthritis of the hip

The effect of low-dose radiotherapy on pain in mild osteoarthritis of the hip - Radiotherapy for pain in osteoarthritis of the hip

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41561
Enrollment
60
Registered
2015-01-21
Start date
2016-02-04
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis and hip joint degeneration

Interventions

None listed

Sponsors

Orbis Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Painful, low-grade osteoarthritis of the hip (Kellgren-Lawrence graad I-II) Above 50 years old Synovitis confirmed with ultrasound imaging Ability and willingness to follow instructions and to return for follow-up evaluations

Exclusion criteria

Exclusion criteria: Patients diagnosed with reumathoid arthritis Patients with osseous metastasis Patients with rheumatoid factor > 20 kU/l or blood sedimentation rate > 20mm Patients with a moderate or severe osteoarthritis grade (Kellgren-Lawrence graad III-IV) Patients with a hip/spine dilemma Prostethic implant in the affected joint Not able or willing to undergo bone scintigraphy or blood sampling

Design outcomes

Primary

MeasureTime frame
Objectives Primary objective. •To determine the effect of LDRT on pain sensation after 1,2, 3 and 6 months in early osteoarthritis of the hip, measured with a Visual Analogue Scale (VAS)

Secondary

MeasureTime frame
Secondary objectives •To determine the effect of LDRT on patient reported outcome measures (PROM) including WOMAC and Oxford Hip Score. •To determine the effect of LDRT on quality of life, assessed through the EuroQoL-5D questionnaire. •To investigate the relationship between effect of LDRT and level of synovitis, measured through ultrasound, bone scintigraphy and blood BSE level.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)